KB
KRYS
HealthcareKrystal Biotech, Inc.
Price Chart
Loading...
Market Data
Revenue TTMXBRL
—
Net IncomeXBRL
—
Gross MarginXBRL
—
EPS (Diluted)XBRL
—
No analysis generated yet. Run the pipeline for this company.
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
5
EarningsBearishPer-CompanyMar 19, 2026
Krystal Biotech Q4 EPS $1.70 beats estimates, revenue $107.1M misses expectations
- ▸Q4 EPS $1.70 vs $1.62 estimate; revenue $107.1M up 17.5% YoY
- ▸Full-year 2025 product revenue $389.1M, up 34% year-over-year
- ▸Vyjuvek sales drove 100% of quarterly revenue
- ▸Cash and investments totaled $955.9M as of Dec 31, 2025
- ▸2026 combined R&D and SG&A expense guidance $175M–$195M